Preclinical drug development

搜索文档
Hesperos and Bayer Consumer Health Develop First Human-on-a-Chip® Model of Stress-Induced Cognitive Dysfunction
Businesswire· 2025-10-07 17:00
ORLANDO, Fla.--(BUSINESS WIRE)-- #BiotechNews--Hesperos, Inc. (Hesperos), a global leader focused on improving preclinical drug development, food, cosmetic, and chemical testing with its Human-on-a-Chip® (HoaC) single- and multi-organ systems platform, is pleased to announce the publication of a new peer- reviewed study, developed in collaboration with Bayer Consumer Health. The study introduces the first human- relevant microphysiological system (MPS) capable of modeling central nervous system (CNS) stress ...